Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

by Hanh Thi Pham, Meng A Xiao, Miguel AV Principe, Alexander Wong, Thibault Mesplède
Published 2020-03-01